It is a common experience that internal states can affect sensory perception, thereby regulating specific behaviors [1] [2] [3] [4] [5] . For instance, body and interoceptive signals can modulate time perception and consequent behaviors in humans 2 . One of the most prominent examples of these processes is the ability of hunger to increase olfactory performance to facilitate the retrieval and the ingestion of food [4] [5] [6] [7] [8] . However, the brain mechanisms governing the link between hunger, olfaction and food intake remain poorly understood. The endocannabinoid system is an important component of the central regulation of energy balance, and cannabinoid intoxication increases food intake 9, 10 . Recently, the use of conditional mutant mice lacking the expression of the type-1 cannabinoid (CB 1 ) receptor (also known as Cnr1) from cortical glutamatergic neurons in the dorsal telencephalon, including neurons located in neocortex, paleocortex and archicortex (Glu-CB 1 −/− ) revealed that (endo)cannabinoiddependent control of excitatory neurotransmission from cortical glutamatergic neurons is necessary to promote fasting-induced food intake 11 . Notably, cannabinoid drugs alter sensory perception, including olfaction 12,13 , suggesting a potential link between these two effects of brain (endo)cannabinoid signaling. However, the specific brain regions, neuronal circuits and mechanisms involved have not yet been identified. We addressed this issue and found that CB 1 receptor-dependent control of excitatory drive from centrifugal feedback projections to the olfactory bulb determines the efficiency of olfactory processes and food intake in fasted mice.
a r t I C l e S
It is a common experience that internal states can affect sensory perception, thereby regulating specific behaviors [1] [2] [3] [4] [5] . For instance, body and interoceptive signals can modulate time perception and consequent behaviors in humans 2 . One of the most prominent examples of these processes is the ability of hunger to increase olfactory performance to facilitate the retrieval and the ingestion of food [4] [5] [6] [7] [8] . However, the brain mechanisms governing the link between hunger, olfaction and food intake remain poorly understood. The endocannabinoid system is an important component of the central regulation of energy balance, and cannabinoid intoxication increases food intake 9, 10 . Recently, the use of conditional mutant mice lacking the expression of the type-1 cannabinoid (CB 1 ) receptor (also known as Cnr1) from cortical glutamatergic neurons in the dorsal telencephalon, including neurons located in neocortex, paleocortex and archicortex (Glu-CB 1 −/− ) revealed that (endo)cannabinoiddependent control of excitatory neurotransmission from cortical glutamatergic neurons is necessary to promote fasting-induced food intake 11 . Notably, cannabinoid drugs alter sensory perception, including olfaction 12, 13 , suggesting a potential link between these two effects of brain (endo)cannabinoid signaling. However, the specific brain regions, neuronal circuits and mechanisms involved have not yet been identified. We addressed this issue and found that CB 1 receptor-dependent control of excitatory drive from centrifugal feedback projections to the olfactory bulb determines the efficiency of olfactory processes and food intake in fasted mice. RESULTS CB 1 receptor expression in glutamatergic projections to the MOB As a result of the low levels of CB 1 receptor expression in cortical glutamatergic neurons 14, 15 , detailed anatomical analysis of CB 1 receptor protein expression detected no or only minor differences between Glu-CB 1 −/− mice and wild-type littermates in many brain regions 11, 16 (data not shown). However, a clear reduction of CB 1 receptor staining was evident in the MOB of mutant mice (Fig. 1a-e) . In wild-type MOB, CB 1 receptor protein was virtually absent from the external plexiform layer and the mitral cell layer (MCL), was expressed at low levels in the glomerular layer, and was expressed at moderate levels in the internal plexiform layer (IPL; Fig. 1a,d ). Conversely, CB 1 receptor immunoreactivity was densely observed in the granule cell layer (GCL) of wild-type mice (Fig. 1a,d) . In Glu-CB 1 −/− mice, we detected a marked reduction of CB 1 receptor immunoreactivity in the GCL (Fig. 1a,b ,d-f and Supplementary Table 1), accompanied by a slight, decrease in the IPL (Fig. 1a, 
b,d-f and Supplementary Table 1).
In the glomerular layer, the levels of CB 1 protein staining were too mice did not display any evident reduction of CB 1 mRNA levels in any of the MOB subpopulations (Supplementary Fig. 1 ). Conversely, CB 1 mRNA was abundantly present in the AON (Fig. 1j) . In cortical areas, including the AON, CB 1 mRNA is expressed in two main neuronal populations 14, [21] [22] [23] : approximately half of GABAergic interneurons contain very high levels of the transcript, whereas the majority of pyramidal glutamatergic neurons display moderate-to-low levels of CB 1 mRNA 14, [21] [22] [23] . Similarly to other cortical areas 11, 23 , the AON of Glu-CB 1 −/− mice contained cells expressing high levels of CB 1 mRNA (presumably GABAergic), whereas low-to-moderate CB 1 receptorexpressing neurons were not detectable (Fig. 1k) , confirming the specific deletion of CB 1 in cortical glutamatergic neurons [21] [22] [23] .
Thus, presynaptic CB 1 receptors 14, 24, 25 in the MOB reside mostly on axon terminals of cortical glutamatergic centrifugal projections, which are primarily located in the GCL and partly in the IPL. Altogether, these data suggest that CB 1 receptor modulation of fasting-induced food intake might involve the control of feedback glutamatergic projections from cortical olfactory areas to the MOB. CB 1 in the MOB is necessary for hyperphagia after fasting As expected 26 , a 24-h fast increased the levels of the endocannabinoid anandamide (AEA) in the hypothalamus, but not in the cerebellum of C57BL/6N mice ( Supplementary Fig. 2 and Supplementary Table 2) . Notably, a similar increase of AEA levels was also observed in the olfactory bulb of fasted mice ( Fig. 2a and Supplementary  Table 1 ), whereas the levels of the other main endocannabinoid, 2-arachidonoyl-glycerol (2-AG), were not altered (Fig. 2a,  Supplementary Fig. 2 , and Supplementary Tables 1 and 2) . Notably, local infusion of the CB 1 receptor antagonist AM251 (4 µg per side) into the GCL of fasted C57BL/6N mice before re-feeding substantially decreased food intake (Fig. 2b, Supplementary Fig. 3 , and Supplementary Tables 1 and 2), indicating that CB 1 receptor activation in the GCL is necessary for fasting-induced food intake. −/− mice (k) (n = 3 per genotype). Lower panels are higher magnifications of the boxed AON regions in the top panels. PfCtx, prefrontal cortex. Scale bars represent 700 µm (a-c), 0.5 µm (g-i) and 100 µm (d,e,j,k). npg a r t I C l e S whether endocannabinoid signaling in the GCL regulates food intake through inhibition of glutamatergic transmission, we infused the NMDA receptor antagonist MK801 (1 or 2 µg per side) into the GCL of wild-type and Glu-CB 1 −/− littermates. As expected 11 , vehicle-treated mutant mice ate less than control mice ( Fig. 2c and Table 1 ), indicating that CB 1 receptors on glutamatergic terminals in the GCL are required for the fasting-induced decrease of activity of GCL neurons. Overall, these data indicate that the orexigenic functions of the endocannabinoid system after fasting involve a reduction of glutamatergic transmission in the MOB, mediated by CB 1 receptors expressed at corticofugal terminals.
CB 1 in the MOB is sufficient for hyperphagia after fasting In Glu-CB 1 −/− mice, CB 1 is deleted in glutamatergic neurons of many cortical areas 11, 23 . To limit the deletion to specific olfactory cortical regions, we injected an adeno-associated virus encoding Cre recombinase (AAV-Cre) into the AON and the anterior piriform cortex (APC) of mice carrying a loxP-flanked CB 1 gene (CB 1 -flox) 23, 27, 28 to generate mice displaying an almost complete absence of CB1 mRNA in the injected brain region (AON/ APC-CB 1 −/− mice; Fig. 3a) . Notably, AON/APC-CB 1 −/− mice had significantly reduced CB 1 receptor protein at centrifugal glutamatergic terminals in the GCL (Fig. 3b,c Supplementary Fig. 4 and Supplementary Table 2) or in the glomerular layer (Fig. 3b) . AON/APC-CB 1 −/− mice displayed a clear hypophagic phenotype in fasting-re-feeding conditions, very similar to Glu-CB 1 −/− and CB 1 −/− mice 12 ( Fig. 3d and Supplementary  Table 1) . Notably, a clear positive correlation was observed between the levels of CB 1 receptor expression in the GCL (but not in the IPL) and food intake (Fig. 3e, Supplementary Fig. 4 , and Causality is determined by necessity and/or sufficiency relationships between events. Thus, to determine whether CB 1 receptor signaling in corticofugal axons has a sufficient role in fasting-induced food intake, we used the Cre-loxP system to obtain conditional rescue of CB 1 receptor expression 29 . The CB 1 receptor allele was genetically modified by introducing a loxP-flanked stop cassette preceding the open reading frame of the gene to generate the Stop-CB 1 mouse line 29 . Similar to conventional CB 1 −/− mice, these mice fully lacked the expression of the CB 1 receptor protein 29 ( Supplementary Fig. 5 ). However, in the presence of Cre recombinase, the loxP-flanked stop cassette was excised and the CB 1 receptor protein was conditionally re-expressed in rescued mice 29 (Supplementary Fig. 5 ). As in other brain regions 29 ( Supplementary Fig. 5 ), Stop-CB 1 mice lacked CB 1 receptor protein expression in olfactory areas (Fig. 4a) , whereas the immunohistochemical staining pattern was indistinguishable from that of wild-type in mice carrying a global restoration of CB 1 receptor expression (CB 1 -RS mice; Online Methods, Fig. 4a and Supplementary Fig. 5 ). Crossing Stop-CB 1 mice with Nex-Cre mice 23, 30 (Online Methods) to delete the stop cassette in cortical glutamatergic neurons led to the re-expression of CB 1 protein in these neurons 29 (Glu-CB 1 -RS mice; Supplementary Fig. 5 ), including centrifugal glutamatergic terminals in the GCL (Fig. 4a) . Similar to conventional CB 1 −/− mice (refs. 11 and 26), Stop-CB 1 mice were hypophagic in fasting-re-feeding conditions (Fig. 4b) , whereas littermate Glu-CB 1 -RS mice displayed food intake levels that were not different from those of fully rescued CB 1 -RS or wild-type control mice ( Fig. 4b and Supplementary Table 1 ). These results indicate that CB 1 receptors in cortical glutamatergic neurons are sufficient to provide normal fasting-induced food intake.
However, the Glu-CB 1 -RS mice express CB 1 receptors in glutamatergic neurons not only in olfactory circuits (Fig. 4a) , but also in many other brain regions 29 (Supplementary Fig. 5 ). To limit the rescue approach to more specific olfactory circuits, similar to the AON/APC-CB 1 −/− mice described above, we injected AAV-Cre into the AON/APC of Stop-CB 1 mice to generate AON/APC-CB 1 -RS mice. This treatment restored the expression of the CB 1 receptor protein in the GCL ( a r t I C l e S treated with a control AAV (Fig. 4d and Supplementary Table 1) . For unknown reasons, lower levels of food intake were consistently observed in Stop-CB 1 mice, which underwent surgery for local virus infusion, compared with intact mice of the same genotype (Fig. 4b,d) . However, the relative rescue of the hypophagic phenotype of respective Stop-CB 1 control mice was similar in CB 1 -RS, Glu-CB 1 -RS and AON/APC-CB 1 -RS mice (Supplementary Fig. 5 ). These data indicate that CB 1 receptor expression in corticofugal pathways to the MOB is necessary and sufficient to promote fasting-induced food intake.
CB 1 controls feeding via olfactory corticofugal circuits
Exogenous administration of the plant-derived CB 1 receptor agonist ∆ 9 -tetrahydrocannabinol (THC) at low doses (1 mg per kg of body weight) enhanced fasting-induced food intake in wild-type mice 11 ( Fig. 5a,b and Supplementary Table 3 ). This effect was fully blocked by the local infusion of a sub-effective dose of the CB 1 receptor antagonist AM251 (2 µg per side; Fig. 5a and Supplementary Table 3) or of the allosteric NMDA receptor enhancer d-cycloserine (DCS) into the GCL (2 µg per side; Fig. 5b and Supplementary Table 3) , as previously shown with systemic treatments 11 . Thus, the hyperphagic effect of THC requires activation of CB 1 receptors and inhibition of glutamatergic transmission in the GCL, suggesting that centrifugal excitation of the GCL is inversely correlated to food intake in fasted animals. To directly test this hypothesis, we injected an AAV expressing a designer receptor exclusively activated by designer drugs (G q -DREADD) 31, 32 under the control of a minimal Camk2a promoter (AAV-CaMK-DREADD) or a control AAV expressing the fluorescent protein mCherry in the AON/APC region of C57BL/6N mice to obtain AON/APC-DREADD mice ( Fig. 5c and Supplementary  Fig. 6 ). The specific G q -DREADD synthetic agonist clozapine-Noxide (CNO), which activates neurons expressing G q -DREADD 32 ( Supplementary Fig. 6 ), did not alter food intake in control AAV-injected mice (Supplementary Fig. 6 ). However, AON/APC-DREADD mice displayed a strong hypophagia after CNO treatment ( Fig. 5d and Supplementary Table 3) . Notably, the CNO treatment also abolished the hyperphagic effect of THC in the same conditions ( Fig. 5e and Supplementary Table 3 ).
CB 1 signaling in the MOB couples olfaction to feeding
We next investigated whether CB 1 receptor signaling in the MOB modulates food intake by altering olfactory processes in 24-h fasted C57BL/6N mice. First, we measured olfactory habituation by exposing the mice twice to the same odor (almond or banana, diluted at 0.1%, widely used as attractive, but food-unrelated, odors for rodents) 33 and scoring their exploration of the source of the odor. As expected [33] [34] [35] , vehicle-treated mice displayed increased exploration of the odor compared with those treated with an odorless oil control (Fig. 6a) . These values returned to control levels (oil) at the second exposure to the same odor (Fig. 6a) , indicating habituation to olfactory stimuli [33] [34] [35] . Notably, THC (1 mg per kg) impaired olfactory habituation in wildtype mice (Fig. 6a-c, Supplementary Fig. 7 , and Supplementary  Tables 2 and 3 ), but not in Glu-CB 1 −/− mice (Fig. 6b, Supplementary  Fig. 7 , and Supplementary Tables 2 and 3) or in mice receiving an intra-GCL injection of DCS (Fig. 6c, Supplementary Fig. 7 , and Supplementary Tables 2 and 3) .
These results apparently suggest that the decrease of olfactory habituation might represent a causal link between CB 1 receptor-dependent control of glutamatergic transmission in the GCL and food intake. data from a,c,e,g ). Data are presented as mean ± s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001. See Supplementary Table 3 for detailed statistics. npg a r t I C l e S However, when food intake was measured after olfactory habituation, there was no correlation between food intake and exploration (data not shown). Moreover, it is important to note that Glu-CB 1 −/− mice, in addition to not responding to THC, did not show any evident spontaneous phenotype in olfactory habituation experiments (Fig. 6b,  Supplementary Fig. 7 , and Supplementary Tables 2 and 3), whereas they were hypophagic. Thus, alterations of olfactory habituation likely represent a parallel effect of THC, which might be unrelated to food intake (lack of positive correlation) and might not be physiologically regulated by endocannabinoid signaling (lack of phenotypic alteration of Glu-CB 1 −/− mice). To find additional (endo)cannabinoid-dependent olfactory processes, which might reliably explain the control of fasting-induced food intake, we measured threshold for odor detection as an index of odor sensitivity 34 . After scoring baseline exploration of odorless oil, mice were exposed to increasing concentrations of the same odor (almond or banana 33 , from 0.001% to 0.1%) and exploration of the odor source was recorded 34, 35 . THC (1 mg per kg) decreased the threshold of odor detection (Fig. 7a and Supplementary Table 3 ) and this effect was clearly correlated with successive food intake ( Fig. 7b and Supplementary Table 3) . THC is known to exert a biphasic effect on stimulated food intake 10, 11 . Consistently, neither a lower nor a higher dose of THC (0.25 mg per kg and 1.75 mg per kg, respectively) altered food intake ( Supplementary Fig. 8 and Supplementary Table 2) , nor did they alter odor detection, with no correlation between these two behaviors ( Supplementary Fig. 8 and Supplementary Table 2) . Intra-GCL infusion of a sub-effective dose of DCS fully blocked the effect of 1 mg per kg THC on odor detection and proportionally reduced the hyperphagic effect of the CB 1 receptor agonist (Fig. 7c,d and Supplementary Table 3) , suggesting that the effect of THC depends on local decrease of glutamatergic transmission. THC had no effect on odor detection in Glu-CB 1 −/− mice ( Fig. 7e and Supplementary Table 3) , and these mice displayed a spontaneous decrease of odor detection under vehicle conditions ( Fig. 7e and Supplementary Table 3) . Food intake in vehicle-or THC-treated Glu-CB 1 −/− mice and wild-type littermates was positively correlated with odor detection threshold, further suggesting a potential causal relationship between these two processes ( Fig. 7f and  Supplementary Table 3) . Moreover, the inhibitor of the anandamidedegrading enzyme fatty acid amide hydroxylase (FAAH) URB597 (ref. 36) proportionally increased food intake and odor detection in a dose-dependent manner (Fig. 7g,h, Supplementary Fig. 8 , and Supplementary Tables 2 and 3) . Together, these data indicate that both pharmacological and physiological activation of CB 1 receptors in the GCL promote odor detection and proportionally increase food intake in fasted mice.
Cannabinoids modulate synaptic activity in the MOB These genetic and pharmacological data indicate that (endo)cannabinoid signaling in the MOB reduces corticofugal glutamatergic transmission in the olfactory bulb to eventually promote food intake. However, genetic and pharmacological methods cannot provide direct evidence of such a mechanism. To directly test the effect of cannabinoid signaling on glutamatergic transmission from the AON/APC to the MOB, we adopted a combination of optogenetic stimulation of these terminals with local drug treatments and electrophysiological recordings in the MOB of awake head-fixed wild-type mice. An AAV containing the photoactivable Channelrhodopsin-2 a r t I C l e S fused to mCherry (ChR2-mCherry) 37 was injected into the AON/APC of wild-type mice to obtain AON/APC-ChR2 mice, which express ChR2 mainly in the GCL (Fig. 8a) . We recorded extracellular field excitatory postsynaptic potentials (fEPSPs) in the GCL of AON/APCChR2 mice in response to local light stimulation (Fig. 8b,c) . We next examined the effect of WIN on the activity of mitral cell projection neurons in response to the photoactivation of AON/APC axon terminals. We recorded spontaneous mitral cell single-unit firing activity (Fig. 8e) in response to light train stimulation with increasing frequencies up to continuous light stimulation. We observed that patterned AON/APC axon stimulation mainly inhibited mitral cell spontaneous firing in a frequency-dependent manner (Fig. 8f,g and Supplementary Table 3 ), suggesting that AON/APC cortical feedback mostly induces feedforward inhibition onto mitral cell 19, 20 . Notably, local infusion of WIN decreased the magnitude of light-evoked feedforward inhibition of mitral cells firing without affecting mitral cell spontaneous firing rate (Fig. 8f,g and Supplementary Table 3) . Thus, CB 1 receptor activation selectively reduces the cortical inhibition of mitral cell spiking activity.
DISCUSSION
Hunger is a physiological condition driving the search for and ingestion of food. Our results suggest that CB 1 receptor-dependent control of olfactory processes has a determinant role in coupling this internal state with the execution of the behavior (Supplementary Fig. 9 ).
When mice are fed standard chow, the control of cortical glutamatergic transmission by CB 1 receptors is dispensable for the modulation of food intake in non-fasting conditions 11 . This suggests that specific factors associated with fasting likely trigger the hyperphagic function of the endocannabinoid system in these circuits. Feedingrelated molecules, such as ghrelin, orexins or leptin, which alter food intake and olfactory processes 6, 7 , might participate in this CB 1 receptor-dependent mechanism. In addition, a lack of specific nutrients 9 might induce CB 1 receptor potentiation of olfactory processes. On the other hand, CB 1 receptors located on cortical glutamatergic neurons determine the ingestion of novel palatable food in non-fasting conditions 11 . Although we did not test this condition, it will be interesting to extend the involvement of olfactory processes to different modalities of stimulated food intake, such as exposure to palatable food, deprivation of specific nutrients or hormonal treatments. Indeed, our electrophysiological in vivo recordings, performed in non-fasted mice, revealed that cannabinoids can decrease glutamatergic centrifugal activity in these conditions, suggesting that additional endogenous (for example, negative energetic status) or exogenous factors (for example, palatability of the food) are necessary to translate the effect of cannabinoid signaling in the MOB network into increased sensory perception and food intake.
Hyperphagic doses of exogenous cannabinoids are able to modulate both olfactory habituation and odor detection. However, the lack of a spontaneous phenotype in Glu-CB 1 −/− mice in olfactory habituation and the lack of clear correlations between habituation and successive food intake in individual mice suggests that this pharmacological effect might be unrelated to cannabinoid control of food intake. Conversely, olfactory detection, as measured by the odor threshold assay 34 , is strongly correlated with food intake. Detection of lowconcentration odors was decreased in hypophagic Glu-CB 1 −/− mice and was augmented by increasing the endogenous levels of anandamide. Thus, these data suggest that the enhancement of olfactory detection is likely the main mechanism linking (endo)cannabinoid signaling in the olfactory bulb to increased food intake.
We used almond and banana to analyze odor habituation and detection. Despite the fact that these molecules are generally used as non-food-related odors for naive rodents 33 , we cannot exclude that their attractiveness and the (endo)cannabinoid-dependent control of their perception are a result of an innate link to food. Future experiments will be needed to determine whether the (endo)cannabinoiddependent potentiation of olfactory processes and food intake acts on different odor categories, such as neutral or aversive essences.
Olfactory processes are generally considered to be weaker determinants of behavior in humans than in animals. However, this concept might be biased by the fact that olfactory information is processed at lower conscious levels than other sensory inputs in humans. In fact, humans make important decisions unconsciously using olfaction. For instance, partner selection is influenced by unconscious olfaction 38 and odorant cues can alter visual perception 39 . Food intake disorders are often associated with an impaired sense of smell [40] [41] [42] , suggesting causal relationships between these processes. Cannabinoids alter both hunger and smell in humans 10, 12 . To the best of our knowledge, a direct causal relationship between these two effects of cannabinoids has not been shown in humans, and specific experiments should be performed to test this hypothesis.
We found that CB 1 receptor signaling in the olfactory bulb increases odor detection and proportionally promotes food intake, thereby linking hunger, olfaction and food intake (Supplementary Fig. 9 ). These functions of CB 1 receptors are exerted by the presynaptic inhibition of glutamatergic transmission from cortical projections to the MOB. Two recent optogenetic studies revealed the precise functional connections between cortical olfactory areas and the MOB 19, 20 . In particular, a previous study 19 showed that the projections from AON impinge mainly onto granule cells and partly onto mitral cells of the MOB. However, mitral cells also receive a strong di-synaptic inhibition via granule cells 19 . These data are consistent with our c-Fos expression study showing that the inhibitory effect of CB 1 receptor signaling on glutamatergic transmission during fasting led to a decrease of neuronal activity in granule cells of the MOB. An alternative possibility is that activation of CB 1 receptors in the MOB might indirectly affect glutamatergic transmission via different mechanisms. However, our optogenetic in vivo electrophysiological recordings in awake mice directly demonstrate that cannabinoids can decrease excitatory local field potentials induced by centrifugal glutamatergic activity mainly onto inhibitory feedforward granule cells 19 , thereby dis-inhibiting the activity of mitral cells. Nevertheless, our c-Fos data did not show higher numbers of fasting-induced activated mitral cells in wild-type or Glu-CB 1 −/− mice, which could be expected by the decrease in feedforward inhibition. This could be a result of the opposite simultaneous effect of CB 1 receptor activation on glutamatergic centrifugal terminals onto granule cells (decreasing feedforward inhibition of mitral cells) and on direct projections to mitral cells 19 (decreasing excitation of these neurons). Indeed, Glu-CB 1 −/− and AON/APC-CB 1 −/− mice present a slight decrease of CB 1 protein expression in the IPL, where corticofugal projections likely synapse onto mitral cells 18, 19 . Thus, fasting and endocannabinoid signaling might determine the activation of specific network patterns linked to olfactory control of food intake without altering the total number of activated mitral cells. Recent data suggest that cannabinoid effect on inhibitory npg a r t I C l e S synaptic activity in the periglomerular area of the MOB might regulate olfactory processes 13 . However, the participation of periglomerular cells in (endo)cannabinoid control of food intake in our experimental conditions is unlikely. In fact, none of our manipulations altered the expression of CB 1 receptors or c-Fos in this area. Thus, the most parsimonious interpretation of our data is that activation of CB 1 receptors on terminals of feedback cortical centrifugal glutamatergic neurons in the MOB directly reduced the excitatory drive onto granule cells, thereby regulating mitral cell activity to eventually increase odor detection and food intake (Supplementary Fig. 9) .
The effects of THC on odor detection might be based on alterations of memory processes 43 . However, higher doses of THC are usually needed to substantially alter memory performance in rodents. For instance, the 1 mg per kg hyperphagic dose of THC does not affect object recognition memory in either the long-term 44 or short-term version of this task (A. Busquets-García, R. Maldonado, A. Ozaita, personal communication). Thus, although a memory component cannot be excluded, cannabinoid-induced alterations of memory and odor processing likely rely on distinct mechanisms and circuits. Another possibility is that THC might increase the motivation of the individuals 45 to explore the odor source. However, this is rather unlikely, as the enhancing effect of THC in odor source exploration in our detection experiments is present only at lower odor concentrations (0.001% and 0.01%), whereas it vanishes at the highest concentration (0.1%). If THC increased the motivation to explore the odor source, this effect should logically be present at any odor concentration. Thus, despite the fact that memory and motivational confounders cannot be completely ruled out, the data strongly suggest a primary effect of (endo)cannabinoids on odor perception in our experimental conditions.
In conclusion (Supplementary Fig. 9 ), we found that the endocannabinoid-mediated control of cortical glutamatergic transmission in the olfactory bulb links an internal state (hunger) to sensory processing (olfaction) and, eventually, to behavior (food intake). Our results might also contribute to new conceptual frameworks for tackling pathological states. Indeed, altered sensory processes characterize several relevant food intake-related diseases, such as obesity, cachexia and anorexia [40] [41] [42] . Thus, specific interference with CB 1 receptor-dependent hunger-olfaction-food intake circuits will likely help contrasting symptoms and development of these pathological conditions.
METHODS
Methods and any associated references are available in the online version of the paper. saline (0.9% NaCl, vol/vol) with 10% DMSO and 10% Chremophor EL, whereas DCS, MK801 and CNO were dissolved in saline solution. All drugs were prepared fresh just before the experiments.
Fasting-induced food intake. Mice were housed under a 12-h: 12-h dark/light cycle (light on 7 a.m., light off 7 p.m.). Before the experiments, mice were singly housed for at least 7 d. 2 h after the light onset, mice were food deprived for 24 h and then given free access to a pre-weighed amount of standard chow (Standard Rodent Diet A03, SAFE). Food intake was recorded 1 and 2 h after refeeding 11 . Under these conditions, spillage of food was minimal. It was however controlled by inspection of litter and calculated as not eaten food. In these procedures, drugs were administered 30 min before refeeding, and pre-treatments, including CNO, were administered 15 min before drugs. olfactory tests. Olfactory tests were adapted according to refs. 33,50-52. olfactory habituation. Two different neutral 33 odors were used during the test: benzaldehyde (almond) and isopentyl acetate (banana) (Sigma-Aldrich). The odors were diluted with mineral oil. For odor presentations, 5 µl of diluted odorant (0.1%) or plain mineral oil were deposited onto filter paper and then placed inside a holder. Mice were tested after 24 h of fasting and from 4-8 h after the onset of the light cycle that corresponds to the same range used for assessing feeding behavior. Drug injections (immunoprecipitate and intra-MOB) were performed 30 min before the test. For testing, mice were placed into a plastic cage box (testing cage, identical to their home cage) without bedding or food, located in a room different of the housing room. The task consisted of 5-min odor presentations separated by 5-min inter-trial intervals. In a given session, mice were first presented with the holder containing the mineral oil only. They were then presented with the first odorant during two successive trials (habituation). Subsequently, they were presented the second odorants (control odor) (data not shown). Exploration of the odor source was defined as directing the nose at a distance <1 cm from the tip of the holder, with the vibrissae moving, and/or touching it with the nose. The exploration was not scored when the mouse was chewing the object. The testing cage was cleaned with ethanol 70% and water between the sessions. The two odorants used were presented according to a counterbalanced schedule. To evaluate odor thresholds, we used the same protocol, but only one odor was presented at different concentrations starting at 0.001% and then 0.01% and 0.1% subsequently. After testing, mice were returned to the housing room and replaced in their home cage with pre-weighed food. Then, food intake was measured after 1 h. endocannabinoids measurements. Mice were killed under fasting or food ad libitum conditions. Brains were quickly removed and the olfactory bulb, hypothalamus and cerebellum dissected, flash frozen, and stored at −80 °C until analysis. Measurements of AEA and 2-AG were carried out as previously described 53 . Briefly, tissues were homogenized and extracted with chloroform/ methanol/Tris-HCl (50 mM, pH 7.5, 2:1:1, vol/vol) containing internal deuterated standards (AEA-d4 and 2-AG-d5). Mass spectral analyses were performed on a TSQ Quantum triple quadrupole instrument (Thermo-Finnigan) equipped with an atmospheric pressure chemical ionization source and operating in positive ion mode. The amounts of anandamide were determined by isotope-dilution using a calibration curve. Endocannabinoid levels were then normalized by the weight of fresh tissue.
Immunohistochemistry. Mice were anesthetized with chloral hydrate (400 mg per kg body weight), transcardially perfused with phosphate-buffered solution (0.1 M, pH 7.4) and then fixed by 500 ml of 4% formaldehyde (wt/vol) prepared at 4 °C. Serial coronal or sagittal vibrosections were cut at 40 µm and collected in 0.1 M phosphate-buffered solution (pH 7.4) at 20-22 °C. Sections were preincubated in a blocking solution of 10% donkey serum, 0.1% sodium azide (wt/vol) and 0.3% Triton X-100 (vol/vol) prepared in 0.1 M phosphatebuffered solution for 30 min at 20-22 °C. Free-floating sections were incubated with goat polyclonal antibodies raised against a 31 amino acid C-terminal sequence (NM007726) of mouse CB 1 receptor (CB 1 -Go-Af450-1, 2 µg ml −1 , Frontier Science, 1-777-12) for 48 h at 4 °C. The antibody was prepared in 10% donkey serum and phosphate-buffered solution containing 0.1% sodium azide and 0.5% Triton X-100. After several washes, the tissue was incubated with fluorescent antibody to goat conjugated to Alexa 488 (1:200, Jackson ImmunoResearch, cat. no. 305-546-003) for 4 h and then washed in 0.1 M phosphate-buffered solution at 20-22 °C, before being incubated with DAPI (1:20,000) for 10 min. Finally, sections were washed, mounted, dried and coverslipped with DPX (Fluka Chemie AG). The slides were analyzed with an epifluorescence Leica DM6000 microscope (Leica). For light microscopy, the same procedure was used, with the following modifications Briefly, the fixative solution to perfuse mice was made up of 4% formaldehyde (freshly depolymerized from paraformaldehyde), 0.2% picric acid and 0.1% glutaraldehyde (vol/vol) in 0.1 M phosphate-buffered solution. Blocking solution was made of 10% normal horse serum (NHS, vol/vol), 0.1% sodium azide and 0.5% Triton X-100 prepared in Tris-HCl buffered saline (TBS), and primary antibody was prepared in this blocking solution. After incubation with the primary antibody, tissue sections were incubated in a secondary biotinylated horse antibody to goat IgG (1:200, Vector Laboratories, cat. no. BA-9500). After washing, sections were processed by a conventional avidin-biotin peroxidase complex method (ABC Elite, Vector Laboratories). Tissue was incubated in the avidin-biotin complex (1:50) prepared in the washing solution for 1 h at 20-22 °C. Then, sections were washed and incubated with 0.05% diaminobenzidine (wt/vol) in 0.1 M phosphate-buffered solution with 0.5% Triton X-100 and 0.01% hydrogen peroxide (vol/vol), for 5 min at 20-22 °C. Finally, tissue was mounted, dehydrated in graded alcohols (50°, 70°, 96°, 100°) to xylol and coverslipped with DPX. Sections were observed and photographed with a light microscope Zeiss Axiophot. For CB 1 detection by light microscopy after viral injection in the AON, we applied the same protocol described above with some modifications. To sum up, olfactory bulbs were dissected from non-perfused brains and directly placed in paraformaldehyde (4%). After washing in 0.1 M phosphate-buffered solution and cryoprotection with 15% and 30% sucrose, coronal sections were cut at 40 µm in a cryotome, collected in 0.1 M phosphatebuffered solution and incubated in 1% hydrogen peroxide in 0.1 M phosphatebuffered solution for 30 min at 20-22 °C.
Analysis of cB 1 expression in the olfactory bulb. 40-µm-thick olfactory bulb sections from mice of each condition (at least n = 3 each) were analyzed. Image-J (version 1.43u, US National Institutes of Health) was used to quantify CB 1 immunolabeling density (mean gray value) in different layers of the MOB. c-Fos. The protocol was identical as for CB 1 immunofluorescence with some modifications. Primary antibody to c-Fos (1:2,000, Santa Cruz Biotechnology, cat. no. sc-52) was incubated overnight at 4 °C. After washing, the tissue was incubated with fluorescent antibody to rabbit conjugated to Alexa 555 (1:2,000, Invitrogen, cat. no. A-21428) for 4 h. Sections were washed, mounted, dried and coverslipped. The slides were analyzed with an epifluorescence Leica DM6000 microscope (Leica).
Quantification of c-Fos expression in the olfactory bulb. c-Fos-positive cells were counted using the software Metamorph (V 7.0). All images were acquired (CoolSNAP HQ 2 , Photometrics) with the same exposition time. The image analysis system measure the optic density in a surface area, quantifying the number of cell nuclei in the area delimited by the drawn contour surrounding the GCL, MCL and glomerular layer according to an automated cell count. This method detects objects (cells) on basis of a group of pixels with values of optical density above the threshold, which are expressed as number of cells. In each section, the detection level (gray scaling) was chosen above the background level. electron microscopy. Mice were perfused with a fixative solution made up of 4% formaldehyde (freshly depolymerized from paraformaldehyde), 0.2% picric acid and 0.1% glutaraldehyde in 0.1 M phosphate-buffered solution. Vibrosections (40 µm) were preincubated in a blocking solution of 10% bovine serum albumin (BSA, vol/vol), 0.1% sodium azide and 0.02% saponin (vol/vol) in TBS for 30 min at room temperature. Then they were incubated in the primary polyclonal goat antibody to CB 1 as described above prepared in the blocking solution, but with 0.04% saponin, on a shaker for 2 d at 4 °C. After several washes with 1% BSA in TBS, tissue sections were incubated in a secondary 1.4-nm nanogold antigoat antibody (1:100, Fab′ fragment, Nanoprobes) prepared in the same solution as the primary antibody for 3 h on a shaker at 20-22 °C. Then, tissue was washed overnight at 4 °C and postfixed in 1% glutaraldehyde for 10 min. After several washes in double distilled water, gold particles were silver-intensified with a HQ Silver npg
